LR-CHOP-21 regimen

WikiDoc Resources for LR-CHOP-21 regimen
Articles
Most recent articles on LR-CHOP-21 regimen Most cited articles on LR-CHOP-21 regimen Review articles on LR-CHOP-21 regimen Articles on LR-CHOP-21 regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on LR-CHOP-21 regimen Images of LR-CHOP-21 regimen Photos of LR-CHOP-21 regimen Podcasts & MP3s on LR-CHOP-21 regimen Videos on LR-CHOP-21 regimen
Evidence Based Medicine
Cochrane Collaboration on LR-CHOP-21 regimen Bandolier on LR-CHOP-21 regimen TRIP on LR-CHOP-21 regimen
Clinical Trials
Ongoing Trials on LR-CHOP-21 regimen at Clinical Trials.gov Trial results on LR-CHOP-21 regimen Clinical Trials on LR-CHOP-21 regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on LR-CHOP-21 regimen NICE Guidance on LR-CHOP-21 regimen NHS PRODIGY Guidance FDA on LR-CHOP-21 regimen CDC on LR-CHOP-21 regimen
Books
Books on LR-CHOP-21 regimen
News
LR-CHOP-21 regimen in the news Be alerted to news on LR-CHOP-21 regimen News trends on LR-CHOP-21 regimen
Commentary
Blogs on LR-CHOP-21 regimen
Definitions
Definitions of LR-CHOP-21 regimen
Patient Resources / Community
Patient resources on LR-CHOP-21 regimen Discussion groups on LR-CHOP-21 regimen Patient Handouts on LR-CHOP-21 regimen Directions to Hospitals Treating LR-CHOP-21 regimen Risk calculators and risk factors for LR-CHOP-21 regimen
Healthcare Provider Resources
Symptoms of LR-CHOP-21 regimen Causes & Risk Factors for LR-CHOP-21 regimen Diagnostic studies for LR-CHOP-21 regimen Treatment of LR-CHOP-21 regimen
Continuing Medical Education (CME)
CME Programs on LR-CHOP-21 regimen
International
LR-CHOP-21 regimen en Espanol LR-CHOP-21 regimen en Francais
Business
LR-CHOP-21 regimen in the Marketplace Patents on LR-CHOP-21 regimen
Experimental / Informatics
List of terms related to LR-CHOP-21 regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:R2CHOP regimen ;Revlimid-Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen

Overview

LR-CHOP-21 regimen refers to a chemotherapeutic regimen consisting of lenalidomide (revlimid), rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolonegiven every 21 days has high activity in relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Regimen

L/RLenalidomide (Revlimid)

RRituximab

CCyclophosphamide

HDoxorubicin (Hydroxydoxorubicin Hydrochloride)

OVincristine (Oncovin)

PPrednisolone

Indications

• Relapsed or refractory diffuse large B-cell lymphoma (DLBCL).